# Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)

> **NCT04931238** · PHASE2 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- COVID-19
- SARS-CoV-2

## Interventions

- **DRUG:** JS016

## Key facts

- **NCT ID:** NCT04931238
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-20
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2021-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931238, "Efficacy and Safety of JS016 in Patients With SARS-CoV-2 Infection (COVID-19)". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04931238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*